SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare - Quaterly Results

10 Feb 2025 Evaluate
The Top line for the quarter ended December 2024 of Rs. 1253.87 millions up 95.98% from Rs. 639.79 millions.The Net Profit of the company reported a remarkable increase of 497.55% to Rs. 161.22  millions  from Rs. 26.98 millions in previous same quarter.Operating profit surged to 393.89 millions from the corresponding previous quarter of 190.29 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1253.87 639.79 95.98 3511.88 2223.34 57.96 3097.87 2477.02 25.06
Other Income 168.26 223.26 -24.63 697.49 658.69 5.89 891.16 686.44 29.82
PBIDT 393.89 190.29 106.99 1591.20 852.02 86.76 1154.08 246.42 368.34
Interest 13.76 26.08 -47.24 45.15 145.46 -68.96 172.57 208.25 -17.13
PBDT 375.27 163.03 130.18 1531.88 639.89 139.40 877.00 -117.30 -847.66
Depreciation 121.95 123.94 -1.61 365.17 373.24 -2.16 496.11 465.48 6.58
PBT 253.32 39.09 548.04 1166.71 266.65 337.54 380.89 -582.78 -165.36
TAX 92.10 12.11 660.53 417.10 94.64 340.72 111.52 -87.93 -226.83
Deferred Tax -43.54 -0.83 5145.78 -37.04 3.62 -1123.20 -1.35 -4.27 -68.38
PAT 161.22 26.98 497.55 749.61 172.01 335.79 269.37 -494.85 -154.43
Equity 97.79 86.80 12.66 97.79 86.80 12.66 86.80 86.80 0.00
PBIDTM(%) 31.41 29.74 5.62 45.31 38.32 18.23 37.25 9.95 274.48

Shilpa Medicare Share Price

629.95 8.85 (1.42%)
10-Jul-2026 10:29 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1944.60
Dr. Reddys Labs. 1245.70
Cipla 1448.65
Zydus Lifesciences 1154.75
Lupin 2503.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: